tirzepatide uk approval The new weight management ‘Tirzepatide’ medication (brand name Mounjaro®) has been approved for use in the NHS. , is now available to NHS patients nationally., In Dorset around 1,000 Tirzepatide (Mounjaro) approved for type

However, there is not yet any direct evidence that someone's body composition would be worse after stopping weight-loss drugs than before they started

Retatrutide is the lead candidate in this category, but is still in clinical trials

The time to plan is now As new uses for GLP-1 medications arise, we believe plan sponsors should start preparing now for increased demand and develop a program approach that balances appropriate access with maintaining benefit affordability

Sip it slowly

Clinicians treating obesity should screen for the presence of eating disorder psychopathology before prescribing GLP-1RAs, as these medications are contraindicated in cases of overweight or obesity associated with atypical anorexia nervosa, bulimia nervosa, and subthreshold bulimia nervosa